Loading stock data…
Neuronetics (STIM)
$1.73-0.15 (-7.98%)
Market ClosedLast close Jul 24
Neuronetics, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Neuronetics, Inc. in the Healthcare sector is trading at $1.73 with a market capitalization of $87M. Wall Street consensus targets $4.50 (4 analysts), implying a +160.1% move over the next 12 months. The stock is currently 64% below its 52-week high of $4.85, remaining 2.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +160.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $34.45M↓ | $41.78M↑ | $37.30M↓ | $38.11M↑ | $31.98M |
| Gross Profit | $16.15M↓ | $21.70M↑ | $17.11M↓ | $17.76M↑ | $15.74M |
| Operating Income | -$8.99M↓ | -$5.04M↑ | -$7.32M↑ | -$8.06M↑ | -$11.01M |
| Net Income | -$10.79M↓ | -$7.16M↑ | -$9.04M↑ | -$10.12M↑ | -$12.68M |
Peer Comparison
JNJUNHPFE
Fundamentals
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatme...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$86.64M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-279.78%
Volume
Today's trading volume
1.12M
Recent News
Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day
BWAY earns Bull of the Day on expanding Deep TMS adoption, while LULU lands Bear of the Day as slowing growth and falling estimates weigh on outlook.
Bull of the Day: Brainsway (BWAY)
Brainsway shares have rallied more than 60% this year, with more bullish tailwinds at its back.
Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit
Neuronetics, Inc. (NASDAQ:STIM) is one of the 10 High Growth Stocks Insiders Are Buying. On July 6, 2026, Neuronetics, Inc. (NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled […]
Neuronetics Q1 Earnings Call Highlights
Neuronetics (NASDAQ:STIM) reported first-quarter 2026 results that management said were largely in line with expectations, as the company balanced growth in its Greenbrook clinic business with a slight decline in overall NeuroStar revenue. President and CEO Dan Reuvers, who led his first earnings ca
Neuronetics, Inc. Q1 2026 Earnings Call Summary
Moby summary of Neuronetics, Inc.'s Q1 2026 earnings call